Our Deals

Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools

Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio

BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering

Grant Avenue Capital Recapitalizes CREO

QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally

Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering

Access Medical Labs Allies with Grupo Diagnostico Aries to Expand Diagnostic Lab Capabilities into North America

Grenova Completes Growth Recapitalization with Peloton Equity to Accelerate Strategic Objectives

PreventionGenetics acquired by Exact Sciences to Enable Earlier Cancer Detection and Hereditary Cancer Testing

ZebraSci Acquired by BD to Enhance Combination Product Testing Capabilities

Pyxant Labs Receives Majority Investment from ArchiMed

Pyxant Labs Bolsters Capabilities in Acquisition of Covance by Labcorp’s SLC Bioanalytical Site

Haematologic Technologies, Inc. was acquired by Edgewater Capital Partners

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

HistoGeneX combines with Caprion Biosciences via strategic investment from Arsenal Capital Partners

MolecularMD has been acquired by ICON Plc.

Santus Laboratories (owned by HealthEdge Partners) sold Cough/Cold asset to Reliable1 – October 2018

Transposagen Biopharmaceuticals, Inc. has been acquired by Lonza

PhenoPath has been acquired by Quest Diagnostics September 2018

Santus Laboratories (owned by HealthEdge Partners) was purchased by DermaRite (owned by Tailwind Capital Group) August 2018